Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
1(6%)
Results Posted
17%(2 trials)

Phase Distribution

Ph phase_4
1
6%
Ph not_applicable
11
61%
Ph phase_2
2
11%
Ph phase_3
3
17%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution17 total trials
Phase 2Efficacy & side effects
2(11.8%)
Phase 3Large-scale testing
3(17.6%)
Phase 4Post-market surveillance
1(5.9%)
N/ANon-phased studies
11(64.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

18

all time

Status Distribution
Active(1)
Completed(12)
Other(5)

Detailed Status

Completed12
unknown5
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (11.8%)
Phase 33 (17.6%)
Phase 41 (5.9%)
N/A11 (64.7%)

Trials by Status

unknown528%
recruiting16%
completed1267%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT04419597Not Applicable

Hemopatch Safety and Efficacy Evaluation Versus Standard Practice for Sealing the Dura in Cerebrospinal Fluid Leaks

Completed
NCT04904653Phase 4

The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage

Recruiting
NCT02364791Phase 2

A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures

Unknown
NCT04487561Not Applicable

Hemopatch Versus Axillary Drainage After Axillary Lymphadenectomy

Completed
NCT03392662

Hemopatch Performance Evaluation: A Prospective Observational Registry

Completed
NCT04185922Not Applicable

Hemopatch to Prevent Lymphatic Leak After Robotic Prostatectomy and Pelvic Lymph Node Dissection

Completed
NCT03419676Phase 3

Use of Hemopatch as a Sealant at the Pancreaticojejunostomy After Pancreatoduodenectomy

Completed
NCT02633670Not Applicable

Hemopatch Versus No Hemopatch (Renal Transplant)

Completed
NCT03410914Phase 2

Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy

Completed
NCT04185480Not Applicable

Evaluating Hemopatch in Reducing Seroma Related Complications Following Axillary Lymph Node Dissection: a Pilot Study

Completed
NCT02491671Phase 3

Effectiveness Novel Tissue Sealant, Prevention Prolonged Air Leak (PAL) After Lung Resection

Completed
NCT03993067Not Applicable

Hemopatch as a Tool to Prevent Biliary Fistula in Liver Surgery.

Completed
NCT03450265Not Applicable

Hemopatch Compared to TachoSil in Postoperative Air Leak Duration After Pulmonary Resection

Completed
NCT02769754Phase 3

Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection

Unknown
NCT03166683Not Applicable

Standard of Care Versus Hemopatch® During Liver Resection

Unknown
NCT03323359Not Applicable

Efficacy and Tolerability of Hemopatch After Hepatic Resection

Unknown
NCT02133378Not Applicable

Prospective Clinical Trial of the Hemopatch Topic Hemostatic in Cardiac Surgery

Completed
NCT02589483Not Applicable

Reinforcement of Rectal Anastomosis-RORA

Unknown

All 18 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
18